BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37317911)

  • 21. Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice.
    Mowers EL; Skinner B; McLean K; Reynolds RK
    J Minim Invasive Gynecol; 2015; 22(4):601-6. PubMed ID: 25596464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic Resonance Imaging Grading System for Preoperative Diagnosis of Leiomyomas and Uterine Smooth Muscle Tumors.
    Suzuki Y; Wada S; Nakajima A; Fukushi Y; Hayashi M; Matsuda T; Asano R; Sakurai Y; Noguchi H; Shinohara T; Sato C; Fujino T
    J Minim Invasive Gynecol; 2018; 25(3):507-513. PubMed ID: 29079462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Giant uterine mass with uterine smooth muscle tumor of uncertain malignant potential: A case report.
    Jang TK; Kwon SH; Cho CH; Lee HW; Shin SJ
    Gynecol Oncol Rep; 2020 Nov; 34():100663. PubMed ID: 33204794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ["STUMP" (smooth muscle tumour of uncertain malignant potential), a tumour of the uterus in pregnancy--a diagnostic and therapeutic challenge].
    Clauss S; Höller S; Hegi L; Blum R; Hösli I
    Z Geburtshilfe Neonatol; 2010 Apr; 214(2):74-7. PubMed ID: 20411475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): A retrospective study in a single center.
    Zhang C; Gao J; Lu S; Zhang Y; Zhu H
    Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():74-79. PubMed ID: 34467879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions.
    Croce S; Ribeiro A; Brulard C; Noel JC; Amant F; Stoeckle E; Devouassoux-Shisheborah M; Floquet A; Arnould L; Guyon F; Mishellany F; Garbay D; Cuppens T; Zikan M; Leroux A; Frouin E; Duvillard P; Terrier P; Farre I; Valo I; MacGrogan GM; Chibon F
    Mod Pathol; 2015 Jul; 28(7):1001-10. PubMed ID: 25932961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: Clinicopathologic-Sonographic Characteristics, Follow-Up and Recurrence.
    Bacanakgil BH; Deveci M; Karabuk E; Soyman Z
    World J Oncol; 2017 Jun; 8(3):76-80. PubMed ID: 29147439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinicopathologic study of uterine smooth muscle tumours of uncertain malignant potential (STUMP).
    Ng JS; Han A; Chew SH; Low J
    Ann Acad Med Singap; 2010 Aug; 39(8):625-8. PubMed ID: 20838704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case report: Spontaneous rupture of leiomyosarcoma uteri 8 months after primary laparoscopic surgery of STUMP.
    Bicanin-Ilic M; Ilic I; Dimitrijevic A; Mujkovic S; Jovic N; Rakic D; Arsenijevic N; Nikolic-Turnic T; Balovic G; Peric A; Mitrovic A; Nikolov A
    Front Med (Lausanne); 2024; 11():1407546. PubMed ID: 38912336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiparametric MR evaluation of uterine leiomyosarcoma and STUMP versus leiomyoma in symptomatic women planned for high frequency focussed ultrasound: accuracy of imaging parameters and interobserver agreement for identification of malignancy.
    Aminzadeh P; Alibrahim E; Dobrotwir A; Paul E; Goergen S
    Br J Radiol; 2021 Mar; 94(1119):20200483. PubMed ID: 33507806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smooth Muscle Tumors of the Uterus at MRI: Focus on Leiomyomas and FIGO Classification.
    Tu W; Yano M; Schieda N; Krishna S; Chen L; Gottumukkala RV; Alencar R
    Radiographics; 2023 Jun; 43(6):e220161. PubMed ID: 37261965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma.
    Lin G; Yang LY; Huang YT; Ng KK; Ng SH; Ueng SH; Chao A; Yen TC; Chang TC; Lai CH
    J Magn Reson Imaging; 2016 Feb; 43(2):333-42. PubMed ID: 26383110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Uterine
    Cao F; Zhong M; Liu CR
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):370-374. PubMed ID: 37042153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases.
    Ip PP; Cheung AN; Clement PB
    Am J Surg Pathol; 2009 Jul; 33(7):992-1005. PubMed ID: 19417585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Criteria for risk stratification of vulvar and vaginal smooth muscle tumors: a follow-up study with application to leiomyoma variants, smooth muscle tumors of uncertain malignant potential, and leiomyosarcomas.
    Swanson AA; Howitt BE; Schoolmeester JK
    Hum Pathol; 2020 Sep; 103():83-94. PubMed ID: 32687944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
    Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
    Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STUMP, a surprise finding in a large fibroid uterus in a 20-year-old woman.
    Hughes L; Roex A; Parange A
    Int J Womens Health; 2018; 10():211-214. PubMed ID: 29765254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent Uterine Smooth-Muscle Tumors of Uncertain Malignant Potential (STUMP): State of The Art.
    Rizzo A; Ricci AD; Saponara M; DE Leo A; Perrone AM; DE Iaco P; Pantaleo MA; Nannini M
    Anticancer Res; 2020 Mar; 40(3):1229-1238. PubMed ID: 32132019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of fibroblast growth factor 2 in patients with uterine smooth muscle tumors: an immunohistochemical study.
    Bodner-Adler B; Mayerhofer K; Czerwenka K; Kimberger O; Koelbl H; Bodner K
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():62-67. PubMed ID: 27825029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors.
    Croce S; Ducoulombier A; Ribeiro A; Lesluyes T; Noel JC; Amant F; Guillou L; Stoeckle E; Devouassoux-Shisheboran M; Penel N; Floquet A; Arnould L; Guyon F; Mishellany F; Chakiba C; Cuppens T; Zikan M; Leroux A; Frouin E; Farre I; Genestie C; Valo I; MacGrogan G; Chibon F
    Mod Pathol; 2018 May; 31(5):816-828. PubMed ID: 29327710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.